OUR PRODUCTS

MOBILE APPS

GENERAL INFO

HRMY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Harmony Biosciences Holdings (HRMY) Earnings Date & Reports

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HRMY is expected to report earnings to fall 13.32% to 79 cents per share on November 04

Harmony Biosciences Holdings HRMY Stock Earnings Reports

Q3'25

Est.

$0.80

Q2'25

Beat

by $0.20

Q1'25

Beat

by $0.42

Q4'24

Beat

by $0.39

Q3'24

Beat

by $0.12

The last earnings report on August 05 showed earnings per share of 92 cents, beating the estimate of 72 cents. With 46.52K shares outstanding, the current market capitalization sits at 1.97B.

View a ticker or compare two or three

Compare

Earnings Traders Earnings Traders

Annualized Return+23%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

HRMY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For HRMY
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HRMY showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

630 West Germantown Pike

Phone

+1 484 539-9800

Employees

246

Web

https://www.harmonybiosciences.com